Company intelligence / Profile preview

Matter Neuroscience

Boulder, Colorado, United Statesmatter.xyz ↗

Ownership: Private
Development stage: Preclinical

Overview

Matter Neuroscience has conducted clinical studies using fMRIs to monitor brain activity related to happiness and well-being. The company plans to present results of its studies analyzing the neuroscience behind positive emotions at the Organization for Human Brain Mapping Annual Meeting in Seoul, South Korea. They have reported early positive results on subjective well-being and brain markers in clinical studies[3].

Therapeutic areas: PsychiatryNeurology
Industry: Medical Imaging

Partnerships

Maastricht University Brain Imaging CenterHappiness Research InstituteIcahn School of Medicine at Mount Sinai

Beyond the preview

Go deeper on Matter Neuroscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Matter Neuroscience.

Explore the full profile